TREATMENT OF COMORBID PATHOLOGY OF CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Keywords:
heart failure, diabetes mellitus, pathogenesis, treatment.Abstract
The article presents data from a scientific study on the role of the influence of comorbid pathologies such as: diabetes mellitus (DM) in patients with chronic heart failure (CHF), pathogenetic mechanisms for the development of heart failure in patients with DM, risk factors for developing CHF (hyperglycemia, increased body mass index, age, coronary heart disease, nephropathy, proteinuria, duration of diabetes, etc.). The results of the analysis of mortality in patients with or without DM depending on the ejection fraction are shown. The characteristics of various drugs for the treatment of CHF, including in patients with DM, are given, promising directions for the treatment of this group of patients are highlighted. Treatment has been shown to be effective with lifestyle changes: weight loss, exercise, diet, etc. in obese patients with and without DM.
References
Atroshchenko E. S., Kadochnikov N. G., Solovej S. P. Faktory serdechno-sosudistogo riska u zhenshchin i muzhchin s saharnym diabetom 2-go tipa, gospitalizirovannyh v stacionar // Probl. zhenskogo zdorov'ya. 2010. T. 5. № 1. S. 29–34.
Ablina K. N., Mkrtumyan A. M., Kakorin S. V. Hronicheskaya serdechnaya nedostatochnost' u pacientov s ishemicheskoj bolezn'yu serdca pri saharnom diabete 2 tipa // Doktor.Ru. Ginekologiya Endokrinologiya. 2015. № 1 (102). S. 55–58.
Belenkov YU. N., Mareev V. YU. Serdechno-sosudistyj kontinuum // Serdechnaya nedostatochnost'. 2002. № 11. S. 7–11.
Bolatchiev H. L., Bolatchieva F. B. Hronicheskaya serdechnaya nedostatochnost' i saharnyj diabet: rasprostranennost', morfologicheskie izmeneniya // Uspekhi sovrem. estestvoznaniya. 2006. № 1. S. 35–40.
Dedov I.I., SHestakova M.V., Majorov A.YU., i dr. Algoritmy specializirovannoj medicinskoj pomoshchi bol'nym saharnym diabetom. / Pod red. Dedova I.I., SHestakovoj M.V., Majorova A.YU. - 8-j vypusk // Saharnyj diabet. - 2017. - T. 20. - №1S. - C. 1-121.
Makolkin V. I., Zyabrev F. N. Primenenie beta-adrenoblokatorov pri hronicheskoj serdechnoj nedostatochnosti: fokus na bisoprolol // Lechashchij vrach. 2012. № 2. S. 12–14.
Obrezan A.G., Kulikov N.V. Hronicheskaya serdechnaya nedostatochnost' i saharnyj diabet: patogenez i vozmozhnosti lecheniya. Kardiologiya. 2018;58(7):85-94. https://doi.org/10.18087/cardio.2018.7.10156
Lityaeva T.YU. Lechenie hronicheskoj serdechnoj nedostatochnosti u bol'nyh saharnym diabetom tipa 2 v klinicheskoj praktike. Byulleten' sibirskoj mediciny. 2011;10(4):119-122. https://doi.org/10.20538/1682-0363-2011-4-119-122
Pochinka I. G. Osobennosti produkcii faktora nekroza opuholi u bol'nyh hronicheskoj serdechnoj nedostatochnost'yu, stradayushchih saharnym diabetom 2 tipa // Sb. st. X Mezhregional'nogo kardiologicheskogo foruma. Nizhnij Novgorod, 2006. S. 135–138.
Petunina N.A., Truhin I.V., Truhina L.V., Sizova ZH.M., Zaharova V.L. Serdechnaya nedostatochnost' i saharnyj diabet: vzglyad na komorbidnost'. Saharnyj diabet. 2019;22(1):79-87. https://doi.org/10.14341/DM9784
Severina A. S., SHestakova M. V. Narushenie sistemy gemostaza u bol'nyh saharnym diabetom // Saharnyj diabet. 2004. № 1. S. 62–67.12. Auni G., Seppo L., Japani R. et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects // Diabetes Care. 2008. №31 (4). Р. 714—719.
Zaripova D.Ya., Negmatullaeva M.N., Tuxanova D.I. The role of Aleandronic acid (Ostalon) in the treatment of perimenopausal osteoporosis. Dr. Ahborotnomasi 2019; 4 (3) Pages 23-27
